Influence of acetazolamide loading on the (in vitro) performances of non-phospholipid-based cationic nanosized emulsion in comparison with phospholipid-based anionic and neutral-charged nanosized emulsions

References

• Kaur IP, Smitha R, Aggarwal D, Kapil M. (2002). Acetazolamide: future perspective in topical glaucoma therapeutics. Int J Pharm, 248:1–14.
   PubMed Web of Science ®Google Scholar
• Maus TL, Larsson LI, McLaren JW, Brubaker RF. (1997). Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol, 115:45–49.
   PubMed Web of Science ®Google Scholar
• Duffel MW, Ing IS, Segarra TM, Dixson JA, Barfknecht CF, Schoenwald RD. (1986). N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure. J Med Chem, 29:1488–1494.
   PubMed Web of Science ®Google Scholar
• Friedman Z, Allen RC, Raph SM. (1985). Topical acetazolamide and methazolamide delivered by contact lenses. Arch Ophthalmol, 103:963–966.
   PubMed Web of Science ®Google Scholar
• Tous SS, Nasser KAE. (1992). Acetazolamide topical formulation and ocular effect. STP Pharm Sci, 2:125–131.
   Google Scholar
• Loftsson T, Frithriksdóttir H, Stefánsson E, Thórisdóttir S, Guthmundsson O, Sigthórsson T. (1994). Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J Pharm Pharmacol, 46:503–504.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R. (2002). Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm, 28:473–493.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Singh M, Kanwar M. (2000). Formulation and evaluation of ophthalmic preparations of acetazolamide. Int J Pharm, 199:119–127.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm, 269:1–14.
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm, 306:71–82.
   PubMed Web of Science ®Google Scholar
• El-Gazayerly ON, Hikal AH. (1997). Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm, 158:121–127.
   Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharmscitech, 8:1.
   PubMed Web of Science ®Google Scholar
• Tamilvanan S. (2008). Oil-in-water nanosized emulsions: medical applications. In: Gad SC, ed. Pharmaceutical Manufacturing Handbook. Hoboken, NJ: John Wiley & Sons Publishers, Chapter 7.4, pp. 1329–1368.
   Google Scholar
• Tamilvanan S, Benita S. (2004). The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm, 58:357–368.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. (2008). Nanotechnology in ocular drug delivery. Drug Discov Today, 13:144–151.
   PubMed Web of Science ®Google Scholar
• Novagali Pharma completed a new Phase II with Cyclokat® in dry eye, Novagali Pharma Press Release-2009, accessed on January 20, 2010 at http://www.novagali.com
   Google Scholar
• Rojanasakul Y, Robinson JR. (1989). Transport mechanisms of the cornea: characterization of barrier permselectivity. Int J Pharm, 55:237–246.
   Web of Science ®Google Scholar
• Rabinovich-Guilatt L, Couvreur P, Lambert G, Goldstein D, Benita S, Dubernet C. (2004). Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions. Chem Phys Lipids, 131:1–13.
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Khoury K, Gilhar D, Benita S. (2001). Ocular delivery of cyclosporin A. I. Design and characterization of cyclosporin A-loaded positively-charged submicron emulsion. STP Pharm Sci, 11:421–426.
   Google Scholar
• Christensen D, Kirby D, Foged C, Agger EM, Andersen P, Perrie Y et al. (2008). Alpha,alpha′-trehalose 6,6′-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying. Biochim Biophys Acta, 1778:1365–1373.
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Kumar BA, Senthilkumar SR, Baskar R, Sekharan TR. (2010). Stability assessment of injectable castor oil-based nano-sized emulsion containing cationic droplets stabilized by poloxamer–chitosan emulsifier films. AAPS Pharmscitech, 11:904–909.
   PubMed Web of Science ®Google Scholar
• Ajith Kumar B, Pandian S, Saravanan R, Tamilvanan S. (2008). Development of acetazolamide-loaded nanosized emulsions (o/w-type) for topical application into eye to reduce intraocular pressure in glaucomatous condition. Indian Association of Pharmaceutical Scientists & Technologists (IAPST) Conference, held at College of Pharmacy, Madras Medical College, Chennai, India, on November 23, 2008, Abstract no. 278.
   Google Scholar
• Parasrampuria J, Das Gupta V. (1990). Development of oral liquid dosage forms of acetazolamide. J Pharm Sci, 79:835–836.
   PubMed Web of Science ®Google Scholar
• Wang LX, He HB, Tang X, Shao RY, Chen DW. (2006). A less irritant norcantharidin lipid microspheres: formulation and drug distribution. Int J Pharm, 323:161–167.
   PubMed Web of Science ®Google Scholar
• Férézou J, Nguyen TL, Leray C, Hajri T, Frey A, Cabaret Y et al. (1994). Lipid composition and structure of commercial parenteral emulsions. Biochim Biophys Acta, 1213:149–158.
   PubMed Web of Science ®Google Scholar
• Groves MJ, Wineberg M, Brain APR. (1985). The presence of liposomal material in phosphatide stabilized emulsions. J Disper Sci Technol, 2:237–247.
   Google Scholar
• Zhang HY, Tang X, Li HY, Liu XL. (2007). A lipid microsphere vehicle for vinorelbine: stability, safety and pharmacokinetics. Int J Pharm, 348:70–79.
   PubMedGoogle Scholar
• Palma SD, Tartara LI, Quinteros D, Allemandi DA, Longhi MR, Granero GE. (2009). An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration. J Control Release, 138:24–31.
   PubMed Web of Science ®Google Scholar
• Moses RA. (1981). ADLER’S Physiology of the Eye Clinical Application. St. Louis, MO: The C.V. Mosby Company, pp. 16–23.
   Google Scholar
• Camber O. (1985). An in vitro model for determination of drug permeability through the cornea. Acta Pharm Suec, 22:335–342.
   PubMedGoogle Scholar
• Schoenwald RD, Huang HS. (1983). Corneal penetration behavior of beta-blocking agents I: physiochemical factors. J Pharm Sci, 72:1266–1272.
   PubMed Web of Science ®Google Scholar
• He CX, He ZG, Gao JQ. (2010). Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs. Expert Opin Drug Deliv, 7:445–460.
   PubMed Web of Science ®Google Scholar
• Grigoriev DO, Miller R. (2009). Mono- and multilayer covered drops as carriers. Curr Opin Colloid Interface Sci, 14:48–59.
   Web of Science ®Google Scholar
• Saito H, Kawagishi A, Tanaka M, Tanimoto T, Okada S, Komatsu H et al. (1999). Coalescence of lipid emulsions in floating and freeze–thawing processes: examination of the coalescence transition state theory. J Colloid Interface Sci, 219:129–134.
   PubMed Web of Science ®Google Scholar
• Ausborn M, Schreier H, Brezesinski G, Fabian H, Meyer HW, Nuhn P. (1994). The protective effect of free and membrane bound cryoprotectants during freezing and freeze-drying of liposomes. J Control Rel, 30:105–116.
   Web of Science ®Google Scholar
• Komatsu H, Okada S, Handa T. (1997). Suppressive effects of salts on droplet coalescence in a commercially available fat emulsion during freezing for storage. J Pharm Sci, 86:497–502.
   PubMed Web of Science ®Google Scholar
• Strauss G, Hauser H. (1986). Stabilization of lipid bilayer vesicles by sucrose during freezing. Proc Natl Acad Sci usa, 83:2422–2426.
   PubMed Web of Science ®Google Scholar
• Harada T, Yokomizo K. (2000). Demulsification of oil-in-water emulsion under freezing conditions: effect of crystal structure modifier. J Am Oil Chem Soc, 77:859–863.
   Web of Science ®Google Scholar
• Vanapalli SA, Palanuwech J, Coupland JN. (2002). Stability of emulsions to dispersed phase crystallization: effect of oil type, dispersed phase volume fraction, and cooling rate. Colloid Surf A, 204:227–237.
   Web of Science ®Google Scholar
• Hagigit T, Nassar T, Behar-Cohen F, Lambert G, Benita S. (2008). The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions. Eur J Pharm Biopharm, 70:248–259.
   PubMed Web of Science ®Google Scholar
• Bhaskar R, Murphy RSR, Miglani BD, Viswanathan K. (1986). Novel method to evaluate diffusion controlled release of drug from resinate. Int J Pharm, 28:59–66.
   Web of Science ®Google Scholar
• Barar J, Javadzadeh AR, Omidi Y. (2008). Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv, 5:567–581.
   PubMed Web of Science ®Google Scholar
• Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR. (1996). Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol, 48:1147–1152.
   PubMed Web of Science ®Google Scholar
• Abdulrazik M, Tamilvanan S, Khoury K, Benita S. (2001). Ocular delivery of cyclosporin A. Part 2. Effect of submicron emulsion’s surface charge on ocular distribution of topical cyclosporin A. STP Pharm Sci, 11:427–432.
   Google Scholar